List of Figures
Erythema Multiforme Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
Erythema Multiforme Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 21
Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
GlobalData Methodology 37


List of Tables
Erythema Multiforme Therapeutics, Global, Clinical Trials by Region, 2017* 7
Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
Erythema Multiforme Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase, 2017* 17
Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 21
Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25